Alpha‐synuclein (αS) and tau play important roles in the pathology of Parkinson's disease and Alzheimer's disease, respectively, as well as numerous other neurodegenerative diseases. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.